Zimbabwe has turned down a substantial US healthcare agreement worth $367m (272 million pounds) spanning five years because of the United States' demand for confidential biological samples.
The decision became public following a government memo from December was leaked, indicating that President Emmerson Mnangagwa felt the agreement was "unbalanced".
A government spokesperson later explained that the US was requesting biological samples for research and commercial gain while was unwilling to guarantee the resulting advantages from future vaccines.
"We will now turn to the challenging and unfortunate process of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had provided over $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has appealed for continued negotiations to find a agreement acceptable to both sides so the nation's vital HIV treatment initiative can proceed.
Wider Background
This rejection follows a comparable situation in neighbouring Kenya, where a court blocked a related deal with the US following legal challenges were filed about the safety of Kenyans' medical information.
After resuming office recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had overseen aid for the US government, but Trump claimed its spending was "inefficient" and his government was pursuing government-to-government agreements to enhance openness and responsibility.
Based on statements, 16 African countries have to date agreed to these new agreements, constituting over $18.3bn in committed funds.
Specifics of the Rejected Deal
The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this partnership would have delivered immense benefits for Zimbabwean communities, particularly the 1.2 million presently on antiretroviral therapy through US-supported initiatives," Tremont said.
However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".
"Zimbabwe was being asked to share its genetic material and health information over an extended period, with no equivalent assurance of access to any scientific breakthroughs – such as new medicines or tests – that might result from that shared data," his statement read.
"Put simply, our nation would provide the raw materials for medical research without any certainty that the end products would be accessible to our people should a future health crisis emerge."
National Interest and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were disrupting systems already set up through the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with future pandemics.
"This framework is intended to guarantee that when a country provides its data, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the funds to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We encourage further discussions with our US partners on how future collaboration could be designed in a manner that honours the independence and dignity of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but urged that negotiations need to persist given that a large portion of the country's Aids initiatives were funded by external financing.
"If specific concerns arise, such as those relating to information security or agreement terms, these can often be addressed through detailed discussion and negotiated safeguards," it said.
The situation highlights the continuing debate between receiving vital foreign assistance and protecting national sovereignty in an ever more interconnected world.